by Kyle | Jul 25, 2022 | News
The Rapid Quantitative Tear Test for MMP-9 from AXIM Biotechnologies Inc. was featured in a list of DED Diagnostic tools in Optometric Management.com. See the list below: DED Diagnostic Items* BLINK ASSESSMENT iPEDA Blink Analyzer MEIBOMIAN GLAND EXPRESSION Flexx MG...
by Kyle | Jul 21, 2022 | Press Release
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, announced today that its CEO John Huemoeller has been...
by Kyle | Jul 12, 2022 | Press Release
SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company, announced today their publication in collaboration with researchers at Arizona State...
by Kyle | Jul 11, 2022 | News
The biotech firm AXIM Biotechnologies Inc. AXIM reports that it has developed fast, point-of-care tests to help eye doctors detect dry eye syndrome, a big issue in today’s world. It is important to differentiate from simple allergies for proper care and treatment. Up...
by Kyle | May 24, 2022 | Press Release
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases announced today that its scientific team has completed...